Treatment options in HBV
- 31 December 2006
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 44, S77-S83
- https://doi.org/10.1016/j.jhep.2005.11.018
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis BNew England Journal of Medicine, 2004
- New Treatment of Chronic Hepatitis BSeminars in Liver Disease, 2004
- Interferon-α for HBeAg-positive chronic hepatitis BJournal of Hepatology, 2003
- Effect of virological response on post‐treatment durability of lamivudine‐induced HBeAg seroconversionJournal of Viral Hepatitis, 2002
- Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approachPublished by Elsevier ,2001
- The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis BJournal of Hepatology, 2001
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literatureJournal of Hepatology, 1993
- Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferonJournal of Hepatology, 1992
- Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type BJournal of Hepatology, 1990